CALC CalciMedica, Inc.

P/E --
Forward P/E --
Price/Sales --
Beta 1.106
Div Yield --
Market Cap --

Company Analysis

Latest News

CalciMedica Regains Compliance with Nasdaq Minimum Bid Price Requirement

CalciMedica Regains Compliance with Nasdaq Minimum Bid Price Requirement

CalciMedica, Inc. (CALC) announced it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement, resolving a previous deficiency...

🟢 CalciMedica is trading 15.61% up in after-hours trading — no clear company-specific catalyst identified

CalciMedica is trading 15.61% up in after-hours trading at $2.29 after a $1.98 close on September 16, 2026, without a clear company-specific catalyst. -...

🔴 CalciMedica is trading 1.5% down in pre-market

CalciMedica is trading 1.5% down in pre-market at $1.97 after closing at $2.00 on September 14, 2026; no major company-specific announcement, earnings release,...

🔴 CalciMedica is trading 5.66% down today; no clear catalyst identified

On September 11, 2026, CalciMedica is trading 5.66% down at $2.00, and the cause remains uncertain. - No new company-specific announcement or major catalyst...

🔴 CalciMedica is trading 5.88% down today amid hotter wholesale-inflation signals and rate concerns

CalciMedica is trading at $2.16, down -5.88%, after broader market weakness linked to hotter wholesale-inflation signals and renewed Federal Reserve rate...

🟢 CalciMedica is trading 10.89% up today with no clear company-specific catalyst identified

CalciMedica is trading 10.89% up at $2.24, after rising from the September 8 close of $2.02, with no clear company-specific catalyst identified. - The...

🟢 CalciMedica is trading 5.94% up today

CalciMedica is trading 5.94% higher at $2.14 versus its $2.02 close on September 8, 2026; no clear company-specific catalyst has been identified for the...

🟢 CalciMedica is trading 5.94% up in after-hours trading with no clear company-specific catalyst

CalciMedica is trading 5.94% up at $2.14 after closing at $2.02 on September 8, 2026, with no clear company-specific catalyst identified. - The only major...

🔴 CalciMedica is trading 5.53% down today with no clear company-specific catalyst identified

CalciMedica is trading 5.53% down at $2.05, with no clear company-specific catalyst identified for September 8, 2026. • CalciMedica announced participation in...

🔴 CalciMedica is trading 6% down today in pre-market

CalciMedica is trading 6% down now at $2.04 after no clear company-specific announcement was identified for September 8, 2026. - The broader market is mixed...

🔴 CalciMedica is trading 5.8% down in after-hours trading amid rate-hike concerns after strong U.S. jobs data

CalciMedica is trading 5.8% down at $2.04 amid broader-market weakness, after closing at $2.17 on September 4, 2026. - The Nasdaq Composite fell 0.65% and the...

🟢 CalciMedica is trading 5.64% up today after Nasdaq closed its market-value compliance matter

CalciMedica is trading at $2.22, up +5.64% after Nasdaq closed its market-value compliance matter on September 2, 2026. - The company satisfied Nasdaq’s...

🟢 CalciMedica is trading 6.67% up in after-hours trading after Nasdaq closed its market-value compliance matter

CalciMedica is trading 6.67% up at $2.24 after Nasdaq closed its market-value compliance matter on September 2, 2026. - The company satisfied Nasdaq’s...

🟢 CalciMedica is trading 10.25% up today after Nasdaq closed its market-value compliance matter — delisting concerns ease

CalciMedica is trading 10.25% up at $2.21 after Nasdaq closed its market-value compliance matter on September 2, 2026. - The company satisfied Nasdaq’s...

🟢 CalciMedica is trading 7% up today after Nasdaq closed its compliance matter

CalciMedica is trading at $2.14 (+6.98%) after Nasdaq closed its market-value compliance matter on September 2, 2026, following the company’s satisfaction of...

CalciMedica Regains Compliance with Nasdaq Market Value Listing Requirement

CalciMedica Regains Compliance with Nasdaq Market Value Listing Requirement

CalciMedica, Inc. (CALC) announced it has regained compliance with a Nasdaq listing requirement related to the minimum market value of its listed securities...

🟢 CalciMedica is trading 8% up in pre-market amid post-split volatility

CalciMedica is trading 8% up in pre-market at $2.16 after extreme volatility following its 1-for-5 reverse stock split. - The split became effective August...

🔴 CalciMedica is trading 5% down in pre-market amid extreme volatility after its reverse stock split

CalciMedica is trading 5% down in pre-market at $1.90 after extreme volatility following its 1-for-5 reverse stock split. - CalciMedica closed September 1,...

🟢 CalciMedica is trading 10.57% up in after-hours trading

CalciMedica is trading 10.57% up at $2.21 after closing September 1, 2026, at $2.00, with no clear company-specific announcement or late-breaking catalyst...

🔴 CalciMedica is trading 6% down today amid biotech-sector weakness

CalciMedica is trading at $2.01, with a -6.07% change amid a broad September 1, 2026 risk-off session and biotech-sector weakness. - The S&P 500 is down 0.79%...